Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report from gme stock ticker live Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:58 👁 View: 390K times ✓ Published: 16-May-2024
Description: In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer has agreed to pay up to $250 million. The settlement, disclosed in a Delaware court filing last week, is intended to significantly reduce Pfizer’s potential liability, reported Financial Times, citing people familiar with the deal.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)